RISKS AND BENEFITS OF ORAL ANTICOAGULATION THERAPY IN HEMODIALYSIS PATIENTS

被引:0
|
作者
Sileno, Giuseppe [1 ]
Guerini, Alice [1 ]
Torreggiani, Massimo [1 ]
Colucci, Marco [1 ]
Bonelli, Grazia [1 ]
Catucci, Davide [1 ]
Esposito, Vittoria [1 ]
Mariotto, Alice [1 ]
Esposito, Ciro [1 ]
机构
[1] ICS Maugeri Spa, Unit Nephrol & Dialysis, Pavia, Italy
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
SP552
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis
    Kuno, Toshiki
    Takagi, Hisato
    Ando, Tomo
    Sugiyama, Takehiro
    Miyashita, Satoshi
    Valentin, Nelson
    Shimada, Yuichi J.
    Kodaira, Masaki
    Numasawa, Yohei
    Briasoulis, Alexandros
    Burger, Alfred
    Bangalore, Sripal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (03) : 273 - 285
  • [32] Home Hemodialysis: Benefits, Risks, and Barriers
    Tomori, Koji
    Okada, Hirokazu
    RECENT ADVANCES IN DIALYSIS THERAPY IN JAPAN, 2018, 196 : 178 - 183
  • [33] Anticoagulation in Patients with Acute Ischemic Stroke and Atrial Fibrillation—a Balance of Risks and Benefits
    Abhimanyu Beri
    Sujeeth Reddy Punnam
    Cardiovascular Drugs and Therapy, 2008, 22 : 419 - 425
  • [34] CLINICAL IMPACT OF ORAL ANTICOAGULATION THERAPY ON MORTALITY, EMBOLIC AND HEMORRHAGIC EVENTS IN CHRONIC HEMODIALYSIS PATIENTS WITH ATRIAL FIBRILLATION
    Dimitrijevic, Zorica
    Salinger, Sonja
    Tasic, Danijela
    Stojanovic, Miomir
    Paunovic, Karolina
    Mitic, Branka
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 : 418 - 418
  • [35] Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
    Teruko Nakamura
    Taisei Fujisaki
    Motoaki Miyazono
    Maki Yoshihara
    Hiroshi Jinnouchi
    Kenichi Fukunari
    Yuki Awanami
    Yuki Ikeda
    Kohei Hashimoto
    Masatora Yamasaki
    Yasunori Nonaka
    Makoto Fukuda
    Tomoya Kishi
    Yuji Ikeda
    Drugs in R&D, 2018, 18 : 231 - 235
  • [36] Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis
    Nakamura, Teruko
    Fujisaki, Taisei
    Miyazono, Motoaki
    Yoshihara, Maki
    Jinnouchi, Hiroshi
    Fukunari, Kenichi
    Awanami, Yuki
    Ikeda, Yuki
    Hashimoto, Kohei
    Yamasaki, Masatora
    Nonaka, Yasunori
    Fukuda, Makoto
    Kishi, Tomoya
    Ikeda, Yuji
    DRUGS IN R&D, 2018, 18 (03) : 231 - 235
  • [37] Perception of the Risk of Stroke and the Risks and Benefits of Oral Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation: A Cross-Sectional Study
    Hijazi, Mohammad
    Aljohani, Sami
    Alqahtani, Fahad
    Chaker, Zakeih
    Al Hajji, Muhammad
    Al Hallak, Ahmad
    Alkhouli, Mohamad
    MAYO CLINIC PROCEEDINGS, 2019, 94 (06) : 1015 - 1023
  • [38] Risks and benefits of concurrent treatment with antiplatelet and anticoagulation therapy in post-op bioprosthetic aortic valve replacement patients
    Yaghi, Carma
    Masson, Rajeev
    Yamada, Kyoko
    Zhu, Shiyun
    Fong, Christine
    Shirazi, Aida
    LaPunzina, Paul
    Mok, Kenny
    JOURNAL OF CARDIAC SURGERY, 2021, 36 (03) : 879 - 885
  • [39] DOES FRAILTY ALTER THE BENEFITS OF ORAL ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION?
    Madhavan, Malini
    Simon, DaJuanicia
    Piccini, Jonathan
    Ansell, Jack
    Fonarow, Gregg
    Go, Alan S.
    Hylek, Elaine
    Kowey, Peter
    Mahaffey, Kenneth
    Thomas, Laine
    Peterson, Eric
    Gersh, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 448 - 448
  • [40] Striking a Balance Between the Risks and Benefits of Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation: Clinical Updates and Remaining Controversies
    Garwood, Candice L.
    Hwang, Jamie M.
    Moser, Lynette R.
    PHARMACOTHERAPY, 2011, 31 (12): : 1208 - 1220